ACRVVSBTAI• 7 Days (Normalized)
ACRV vs BTAI (Acrivon Therapeutics Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Sep, 11 to Sep, 18, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACRV Performance $1.85
-7.75%
Acrivon Therapeutics Inc.
Normalized Baseline0.00%
BTAI Performance $0.08
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin BTAI LEADS
-7.75%
BTAI outperforming by 7.75%
ACRVBTAI
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACRV BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(6 dates)
| Date | ACRV Price | ACRV Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 18, 2026 | $1.85 | -7.75% | $- | - | |
| Sep 17, 2026 | $1.70 | -15.00% | $0.08 | +47.25% | -62.25% |
| Sep 16, 2026 | $1.70 | -15.00% | $0.07 | +31.18% | -46.18% |
| Sep 15, 2026 | $1.83 | -8.50% | $0.04 | -12.35% | +3.85% |
| Sep 14, 2026 | $1.96 | -2.00% | $0.05 | -11.57% | +9.57% |
| Sep 11, 2026 | $2.00 | +0.00% | $0.05 | +0.00% | +0.00% |